For: | Tang SY, Tan JS, Pang XZ, Lee GH. Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact. World J Gastroenterol 2023; 29(3): 549-560 [PMID: 36688021 DOI: 10.3748/wjg.v29.i3.549] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i3/549.htm |
Number | Citing Articles |
1 |
Muhammed Mubarak. Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities. World Journal of Gastrointestinal Pathophysiology 2024; 15(1): 92864 doi: 10.4291/wjgp.v15.i1.92864
|
2 |
Fahad Lakhdhir, Agha Syed Muhammad, Ahmed Nasir Qureshi, Imran A Shaikh, Imran Joher, Jawaria Majeed, Javaria Khan . Assessing Mortality Disparities Among Non-Alcoholic Fatty Liver Disease Metabolic Dysfunction Fatty Liver Disease and Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.71639
|
3 |
利静 张. Advances in the Study of Small Cell Lung Cancer and Metabolic Syndrome. Asian Case Reports in Emergency Medicine 2025; 13(02): 125 doi: 10.12677/acrem.2025.132020
|
4 |
Dongmin Liu, Siyu Wang, Yaqing Liu, Yong Luo, Beibei Wen, Wenliang Wu, Hongliang Zeng, Jianan Huang, Zhonghua Liu. Fuzhuan brick tea ameliorates hepatic steatosis and steatohepatitis through gut microbiota-derived aryl hydrocarbon receptor ligands in high-fat diet-induced obese mice. Food & Function 2023; 14(18): 8351 doi: 10.1039/D3FO01782F
|
5 |
Tianran Shen, Shupei Wang, Zhihao Wang, Hanlu Jia, Yuan Wei, Yu Li, Qiutong Zheng, Yuting Li, Luanzhao Pan, Qingsong Chen. Association between the traditional Chinese medicine constitution and metabolic dysfunction-associated fatty liver disease in older people: A cross-sectional study. Heliyon 2024; 10(3): e24905 doi: 10.1016/j.heliyon.2024.e24905
|
6 |
Lei Liu, Yufu Zhou, Shuwen Deng, Ting Yuan, Saiqi Yang, Xiaoling Zhu, Changfa Wang, Yaqin Wang. Arterial stiffness progression in metabolic dysfunction–associated fatty liver disease subtypes: A prospective cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(8): 1890 doi: 10.1016/j.numecd.2024.03.030
|
7 |
O.E. Abaturov, A.O. Nikulina. Histones post-translational modifications associated with the development of metabolic dysfunction-associated fatty liver disease. Part 3. Histon acetylation. GASTROENTEROLOGY 2025; 59(1): 56 doi: 10.22141/2308-2097.59.1.2025.664
|
8 |
Xuangao Wu, Ting Zhang, Sunmin Park. Dietary quality, perceived health, and psychological status as key risk factors for newly developed metabolic dysfunction–associated steatotic liver disease in a longitudinal study. Nutrition 2025; 130: 112604 doi: 10.1016/j.nut.2024.112604
|
9 |
Hajime Nawata, Li Ou, Xu Zhang, Qinglan Song, Jing Huang, Jin Hu, Kazue Ito, Shinichi Obo, Takeharu Fukushima, Kaori Iwami, Shizuka Iguchi, Ai Igarashi, Xiaoyang He, Jing Zhang, Yu Xia, Ken Takasaki. Arterial stiffness, high fasting glucose, and fatty liver as risk factors for visceral obesity in middle-aged Chinese individuals: a cross-sectional study. Endocrine Journal 2025; 72(5): 525 doi: 10.1507/endocrj.EJ24-0554
|
10 |
Lucia De la Cruz-Color, Jose Alfredo Dominguez-Rosales, Montserrat Maldonado-González, Bertha Ruíz-Madrigal, Martha P. Sánchez Muñoz, Vianney Alejandrina Zaragoza-Guerra, Victor H. Espinoza-Padilla, Elizabeth del C. Ruelas-Cinco, Sandra M. Ramírez-Meza, José R. Torres Baranda, María del R. González-Gutiérrez, Zamira Helena Hernandez Nazara. Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans. International Journal of Molecular Sciences 2024; 25(12): 6420 doi: 10.3390/ijms25126420
|
11 |
Rebecca D. Kehm, Chrystelle L. Vilfranc, Jasmine A. McDonald, Hui-Chen Wu. County-Level Food Insecurity and Hepatocellular Carcinoma Risk: A Cross-Sectional Analysis. International Journal of Environmental Research and Public Health 2025; 22(1): 120 doi: 10.3390/ijerph22010120
|